A Phase III Study of the Safety and Efficacy of Ferumoxytol (Compared With Oral Iron) as an Iron Replacement Therapy in Hemodialysis Patients Who Are Receiving Supplemental EPO Therapy
Latest Information Update: 06 Apr 2022
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors AMAG Pharmaceuticals
- 15 Sep 2014 New trial record